Details for Patent: 7,973,031
✉ Email this page to a colleague
Which drugs does patent 7,973,031 protect, and when does it expire?
Patent 7,973,031 protects RYDAPT and is included in one NDA.
This patent has thirty-four patent family members in twenty-four countries.
Summary for Patent: 7,973,031
| Title: | Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity |
| Abstract: | The present invention relates to the use of staurosporines derivatives for the preparation of a drug for the treatment of diseases involving deregulated FLT3 receptor tyrosine kinase activity, especially for the curative and/or prophylactic treatment of leukemias and myelodysplastic syndromes, and to a method of treating diseases involving deregulated FLT3 receptor tyrosine kinase activity. |
| Inventor(s): | Griffin; James Douglas (Brookline, MA), Manley; Paul William (Arlesheim, CH) |
| Assignee: | Novartis AG (Basel, CH) Dana-Farber Cancer Institute Inc (Boston, MA) |
| Application Number: | 10/493,786 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,973,031 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,973,031
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | RYDAPT | midostaurin | CAPSULE;ORAL | 207997-001 | Apr 28, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF ADULT PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) WHO ARE FLT3 MUTATION-POSITIVE, IN COMBINATION WITH STANDARD CYTARABINE AND DAUNORUBICIN INDUCTION AND CYTARABINE CONSOLIDATION CHEMOTHERAPY | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,973,031
| PCT Information | |||
| PCT Filed | October 29, 2002 | PCT Application Number: | PCT/EP02/12076 |
| PCT Publication Date: | May 08, 2003 | PCT Publication Number: | WO03/037347 |
International Family Members for US Patent 7,973,031
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 335490 | ⤷ Try a Trial | |||
| Australia | 2006249245 | ⤷ Try a Trial | |||
| Brazil | 0213739 | ⤷ Try a Trial | |||
| Brazil | PI0213739 | ⤷ Try a Trial | |||
| Canada | 2462657 | ⤷ Try a Trial | |||
| China | 101703509 | ⤷ Try a Trial | |||
| China | 1582150 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
